{"AAPL": {"Ticker": "AAPL", "Company": "Apple", "Sector": "Information Technology", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$190 to $210"}, {"Date": "2023-07-17", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$190 to $220"}, {"Date": "2023-07-11", "Rating": "Reiterated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$180 to $200"}, {"Date": "2023-06-30", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$240"}, {"Date": "2023-06-13", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$180 to $190"}, {"Date": "2023-06-06", "Rating": "Downgrade", "Organization": "DA Davidson", "Rating_Change": "Buy to Neutral", "Target_Change": "$193 to $185"}, {"Date": "2023-05-22", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": "$180"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$173 to $198"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$195 to $180"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$170 to $195"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$180 to $185"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Monness Crespi & Hardt", "Rating_Change": "Buy", "Target_Change": "$174 to $188"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$177 to $180"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$170 to $180"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "DA Davidson", "Rating_Change": "Buy", "Target_Change": "$173 to $193"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$180 to $185"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$173 to $176"}, {"Date": "2023-05-05", "Rating": "Reiterated", "Organization": "Atlantic Equities", "Rating_Change": "Overweight", "Target_Change": "$180 to $200"}, {"Date": "2023-05-01", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$168 to $173"}, {"Date": "2023-04-26", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$166 to $170"}, {"Date": "2023-04-26", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$145 to $149"}], "Score": 1.19, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 21, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Rosenblatt", "Atlantic Equities", "Morgan Stanley", "Deutsche Bank", "Barclays", "Needham", "DA Davidson", "Loop Capital", "KeyBanc Capital Markets", "BofA Securities", "UBS", "Monness Crespi & Hardt", "Canaccord Genuity", "Citigroup", "Piper Sandler"], "Price_Target": 189.38}, "T": {"Ticker": "T", "Company": "AT&T", "Sector": "Communication Services", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-07-17", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$22 to $16"}, {"Date": "2023-07-14", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$22 to $17"}, {"Date": "2023-06-06", "Rating": "Upgrade", "Organization": "MoffettNathanson", "Rating_Change": "Underperform to Market Perform", "Target_Change": "$17"}, {"Date": "2023-04-21", "Rating": "Upgrade", "Organization": "HSBC Securities", "Rating_Change": "Hold to Buy", "Target_Change": "$21"}], "Score": -0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["MoffettNathanson", "Argus", "Citigroup", "HSBC Securities", "JP Morgan"], "Price_Target": 17.75}, "BSX": {"Ticker": "BSX", "Company": "Boston Scientific", "Sector": "Health Care", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Initiated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$59"}, {"Date": "2023-06-30", "Rating": "Initiated", "Organization": "CL King", "Rating_Change": "Buy", "Target_Change": "$64"}, {"Date": "2023-05-30", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$58"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Robert W. Baird", "CL King", "Morgan Stanley"], "Price_Target": 60.33}, "CSCO": {"Ticker": "CSCO", "Company": "Cisco Systems", "Sector": "Information Technology", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$55 to $62"}, {"Date": "2023-07-12", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$56"}, {"Date": "2023-06-30", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$54"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["BofA Securities", "Citigroup", "JP Morgan"], "Price_Target": 57.33}, "DHR": {"Ticker": "DHR", "Company": "Danaher Corporation", "Sector": "Health Care", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$270"}, {"Date": "2023-05-01", "Rating": "Initiated", "Organization": "SVB Securities", "Rating_Change": "Outperform", "Target_Change": "$300"}, {"Date": "2023-04-26", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$310 to $250"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Raymond James", "SVB Securities", "BofA Securities"], "Price_Target": 273.33}, "DPZ": {"Ticker": "DPZ", "Company": "Domino's Pizza", "Sector": "Consumer Discretionary", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Reiterated", "Organization": "BTIG Research", "Rating_Change": "Buy", "Target_Change": "$400 to $465"}, {"Date": "2023-07-13", "Rating": "Upgrade", "Organization": "Northcoast", "Rating_Change": "Neutral to Buy", "Target_Change": "$430"}, {"Date": "2023-06-15", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": "$320 to $350"}, {"Date": "2023-06-14", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$349"}, {"Date": "2023-06-01", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$340 to $360"}], "Score": 1.8, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Northcoast", "Stifel", "Piper Sandler", "JP Morgan", "BTIG Research"], "Price_Target": 390.8}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Initiated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$107"}, {"Date": "2023-05-30", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$102"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Robert W. Baird", "Morgan Stanley"], "Price_Target": 104.5}, "INTU": {"Ticker": "INTU", "Company": "Intuit", "Sector": "Information Technology", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Upgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Underperform to Neutral", "Target_Change": "$532"}, {"Date": "2023-04-24", "Rating": "Initiated", "Organization": "Atlantic Equities", "Rating_Change": "Overweight", "Target_Change": "$530"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Atlantic Equities", "Exane BNP Paribas"], "Price_Target": 531.0}, "ISRG": {"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Initiated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$377"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Robert W. Baird"], "Price_Target": 377.0}, "MDT": {"Ticker": "MDT", "Company": "Medtronic", "Sector": "Health Care", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Initiated", "Organization": "Robert W. Baird", "Rating_Change": "Neutral", "Target_Change": "$90"}, {"Date": "2023-06-30", "Rating": "Initiated", "Organization": "CL King", "Rating_Change": "Buy", "Target_Change": "$106"}, {"Date": "2023-05-30", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$104"}, {"Date": "2023-04-24", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$77 to $100"}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Robert W. Baird", "CL King", "Morgan Stanley", "Wells Fargo"], "Price_Target": 100.0}, "RSG": {"Ticker": "RSG", "Company": "Republic Services", "Sector": "Industrials", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$177"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Citigroup"], "Price_Target": 177.0}, "HSY": {"Ticker": "HSY", "Company": "The Hershey Company", "Sector": "Consumer Staples", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Upgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Neutral to Outperform", "Target_Change": "$268"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$255 to $275"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$269 to $310"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$243 to $260"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$260 to $285"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "In-line", "Target_Change": "$255 to $265"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$251 to $264"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$280 to $300"}, {"Date": "2023-04-28", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$245 to $265"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 9, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Barclays", "Exane BNP Paribas", "Deutsche Bank", "BofA Securities", "UBS", "Stifel", "Evercore ISI", "Jefferies", "Wells Fargo"], "Price_Target": 276.89}, "TMO": {"Ticker": "TMO", "Company": "Thermo Fisher Scientific", "Sector": "Health Care", "Updated": "2023-07-19", "Rating": [{"Date": "2023-07-19", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$595"}, {"Date": "2023-07-13", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Outperform", "Target_Change": "$620"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Raymond James", "Credit Suisse"], "Price_Target": 607.5}}